$CLX

Is Clorox’s 6% Dividend Yield Safe? The Nov. 2 Earnings Report Could Decide

Clorox (CLX) reports Q1 2027 earnings on Nov 2, with shares at $87.52 and a 5.7% dividend yield. Last quarter, revenue beat estimates but fell 2% YoY, with gross margin contracting 520 bps. Health and Wellness grew 16%, while other segments declined. Analysts expect Q1 EPS of $1.07 and revenue of $1.88B. Management faces pressure to maintain margins and cash flow to support the dividend.

Original reporting
Published Oct 27, 2026, 1:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 1:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Clorox’s 6% Dividend Yield Safe? The Nov. 2 Earnings Report Could Decide — source image
Decision brief

The 30-second read

$CLXBearishLow
01

Why it matters

The article suggests the dividend may be at risk, which could trigger sell‑offs if guidance falls short.

02

Market read

Focuses on dividend sustainability risk for CLX; limited broader market impact.

03

What to watch

Potential cost‑inflation mitigation from the Purell integration and any hidden cost‑savings could support earnings.

Relevance 4/10Novelty 2/10Timing: ahead of Nov 2 earnings

Background

Clorox's dividend yield of ~6% is under scrutiny as analysts question cash‑flow coverage ahead of its upcoming earnings release.

Company-level read

Ticker impact

$CLXBearishMedium confidence
Context

The article evaluates Clorox's high dividend yield and cash‑flow coverage ahead of its Q1 FY2027 earnings on Nov 2, making the dividend sustainability the primary focus.

Expected impact

likely pressure as the market prices in dividend‑coverage concerns

Evidence & confidence

The piece highlights thin payout ratio, rising debt and margin pressure, which could prompt sellers if guidance disappoints.

Market effects

Dividend‑focused investors may reassess exposure to consumer‑staples with high yields.

Limited to U.S. equity markets; no broader regional effect.

Low; relevance confined to CLX shareholders and dividend‑seeking funds.

Counterpoint

If cash flow improves faster than expected, the dividend could remain sustainable and the stock may rally.

Key entities

  • Clorox

    Consumer‑staples maker with a 10‑year dividend increase streak.

Related articles

$KMBMedAI 8/10

Kimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend

Kimberly-Clark (KMB) and Clorox (CLX) reported earnings, highlighting their respective overhauls. KMB beat EPS estimates with $2.12, but faces China-related challenges. CLX saw gross margin decline due to higher costs. Both have high dividend payout ratios, with CLX offering a higher yield but carrying more debt. KMB's stock is up 10.28% YTD, while CLX is down 11.85%.

$KMBMed

Kimberly-Clark vs. Clorox: Which Dividend Stock Pays You More in 10 Years?

Clorox (CLX) and Kimberly-Clark (KMB) are compared for their dividend payouts. CLX offers a 6.2% yield, but its dividends exceeded free cash flow in fiscal 2026. KMB yields 5.4%, with dividends covered by free cash flow. CLX's net debt increased post-acquisition, while KMB faces China-related sales challenges. Both companies' dividend policies and financial health are analyzed.

$KHCMed

Better High-Yield Dividend Stock: Kraft Heinz vs. Clorox

Kraft Heinz (KHC) and Clorox (CLX) are compared as high-yield dividend stocks. KHC yields 7.2% with a 50% payout ratio, while CLX yields 6.1% with a 149% payout ratio. KHC guided 2026 adjusted operating income down 16-18%, and CLX's free cash flow fell to $405M in fiscal 2026. CLX's debt increased to 4.3x EBITDA post-GOJO deal.

$CLXMed

Can Cost Savings Offset Inflation & Protect Clorox's Margins?

Clorox (CLX) reported a 520 basis point gross margin contraction in Q4 fiscal 2026 due to inflation and mix challenges. The company is focusing on cost savings and productivity initiatives to offset inflationary pressures, but expects margins to remain pressured in fiscal 2027. CLX shares have risen 5.2% in the past three months, with a forward P/E of 15.97X.